The drug companies got rich during the pandemic through massive government subsidies. Now, they want to raise the price of lifesaving treatment. Fostering competition could keep costs down.
Should We Ever Trust Polls Again?
After the Wisconsin gubernatorial primary and Michigan Senate primary, we need to remind ourselves that polls are snapshots of public opinion at best, not firm predictions.
Keep reading
by Bill Scher

